title: Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features.
authors.forename: J A
authors.initials: JA
authors.lastname: Woyach
authors.forename: G
authors.initials: G
authors.lastname: Lozanski
authors.forename: A S
authors.initials: AS
authors.lastname: Ruppert
authors.forename: A
authors.initials: A
authors.lastname: Lozanski
authors.forename: K A
authors.initials: KA
authors.lastname: Blum
authors.forename: J A
authors.initials: JA
authors.lastname: Jones
authors.forename: J M
authors.initials: JM
authors.lastname: Flynn
authors.forename: A J
authors.initials: AJ
authors.lastname: Johnson
authors.forename: M R
authors.initials: MR
authors.lastname: Grever
authors.forename: N A
authors.initials: NA
authors.lastname: Heerema
authors.forename: J C
authors.initials: JC
authors.lastname: Byrd
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D064007:Ataxia Telangiectasia Mutated Proteins; D014408:Biomarkers, Tumor / Q000235:genetics*; D018797:Cell Cycle Proteins / Q000235:genetics; D002872:Chromosome Deletion; D020732:Cytogenetic Analysis; D004268:DNA-Binding Proteins / Q000235:genetics; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005419:Flavonoids / Q000627:therapeutic use*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000235:genetics; D010880:Piperidines / Q000627:therapeutic use*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000235:genetics; D025521:Tumor Suppressor Proteins / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D005419:Flavonoids; D010880:Piperidines; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins; C077990:alvocidib; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases